MB "Baltas drugys" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2020 |
---|
29,181 |
14,518 |
3,812 |
3,812 |
1,897 |
82.03 |
13.06 |
-13,698 |
36,225 |
21,156 |
1,371 |
2021 |
---|
2,100 |
- |
-3,820 |
-3,820 |
- |
100.00 |
-181.90 |
-17,518 |
34,297 |
16,469 |
1,310 |
2022 |
---|
3,000 |
- |
-12,477 |
-12,477 |
- |
61.77 |
-415.90 |
-29,995 |
32,619 |
2,520 |
1,104 |
Register and
explore Okredo data2022 |
---|
3,000 |
- |
-12,477 |
-12,477 |
- |
61.77 |
-415.90 |
-29,995 |
32,619 |
2,520 |
1,104 |
Register and
explore Okredo data2022
Turnover (€)
3,000 €43 % *
Sales per employee (€)
-Profit before tax (€)
-12,477 €-227 % *
Net Profit (€)
-12,477 €-227 % *
Profit per employee (€)
-Total profitability (%)
61.77 %-38.23 % *
Net profitability (%)
-415.90 %-128.64 % *
Equity (€)
-29,995 €-71 % *
Amounts Payable And Liabilities (€)
32,619 €-5 % *
Non-current Assets (€)
2,520 €-85 % *
CurrentAssets (€)
1,104 €-16 % *